| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.38 | $101.41 (0%) | 🛒 Add to cart |
| 60 | $2.71 | $202.82 $162.66 (20%) | 🛒 Add to cart |
| 90 | $2.50 | $304.23 $224.91 (26%) | 🛒 Add to cart |
| 120 | $2.38 | $405.64 $285.15 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $608.46 $407.65 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $912.69 $592.40 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.20 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.80 $70.28 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.40 $91.37 (7%) | 🛒 Add to cart |
| 180 | $0.74 | $147.60 $132.54 (10%) | 🛒 Add to cart |
| 270 | $0.73 | $221.40 $195.79 (12%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $295.19 $258.04 (13%) | 🛒 Add to cart |
Similar products
More info:
Diltiazem: Advanced Calcium Channel Blockade for Cardiovascular Control
Diltiazem hydrochloride is a benzothiazepine-class calcium channel blocker indicated for the management of hypertension, chronic stable angina, and atrial arrhythmias. It functions by inhibiting the influx of calcium ions during cardiac and vascular smooth muscle depolarization, resulting in coronary and peripheral vasodilation with reduced myocardial oxygen demand. This agent offers a favorable hemodynamic profile, making it a cornerstone in cardiovascular therapeutic regimens for appropriate patient populations. Its extended-release formulations provide 24-hour blood pressure control and antianginal efficacy with once-daily dosing convenience.
Avodart: Clinically Proven BPH Symptom Relief and Prostate Health
Avodart (dutasteride) is a prescription medication specifically formulated for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. As a potent 5-alpha-reductase inhibitor, it works by fundamentally altering the hormonal pathway responsible for prostate growth, leading to a significant reduction in prostate volume. This action results in measurable improvements in urinary flow and a decrease in the bothersome symptoms associated with BPH, thereby enhancing quality of life.
Bystolic: Advanced Beta-Blocker Therapy for Hypertension Control
Bystolic (nebivolol) is a beta-blocker medication specifically designed for the management of hypertension. It represents a modern therapeutic option within its class, offering a unique pharmacological profile that combines beta-1 adrenergic receptor blockade with vasodilatory properties. This dual mechanism of action allows for effective blood pressure reduction while potentially mitigating some of the undesirable effects associated with older generation beta-blockers. Clinicians often consider Bystolic for patients requiring a well-tolerated antihypertensive agent, particularly those who may benefit from its hemodynamic and metabolic profile.
Cardizem: Expert Calcium Channel Blocker for Hypertension & Angina Control
Cardizem (diltiazem hydrochloride) is a prescription calcium channel blocker medication indicated for the management of hypertension (high blood pressure) and chronic stable angina. As a cornerstone of cardiovascular pharmacotherapy, it functions by inhibiting calcium ion influx during cardiac and vascular smooth muscle depolarization, resulting in reduced peripheral vascular resistance and decreased myocardial oxygen demand. This dual mechanism offers a targeted approach to cardiovascular management, making it a preferred choice among clinicians for long-term therapy in appropriate patient populations.
Colchicine: Targeted Relief for Gout and Inflammation
Colchicine is a time-tested, potent medication primarily indicated for the treatment and prophylaxis of acute gout flares. It belongs to the class of anti-gout agents and works by inhibiting microtubule polymerization, thereby reducing the migration of neutrophils to inflamed areas and diminishing the inflammatory response. This mechanism provides a targeted approach to managing the intense pain and swelling characteristic of gout attacks. Its use is also established in the management of familial Mediterranean fever (FMF) and other inflammatory conditions, under strict medical supervision.
Dapoxetine: The First SSRI for Premature Ejaculation Management
Dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) specifically developed and approved for the on-demand treatment of premature ejaculation (PE) in adult men. Unlike traditional daily SSRIs used off-label, dapoxetine’s unique pharmacokinetic profile allows for rapid absorption and elimination, making it suitable for use approximately 1–3 hours before anticipated sexual activity. It represents a significant advancement in sexual medicine, offering a clinically proven, purpose-built pharmacological option for a condition that affects a substantial portion of the male population.
Digoxin: Precision Heart Rate Control for Improved Cardiac Function
Digoxin remains a cornerstone in the management of select cardiovascular conditions, offering a unique mechanism of action that distinguishes it from other cardiac medications. As a cardiac glycoside derived from the foxglove plant (Digitalis lanata), it exerts positive inotropic effects to enhance myocardial contractility while providing negative chronotropic control of ventricular rate in atrial fibrillation. Its continued relevance in modern cardiology is supported by decades of clinical evidence and well-established therapeutic protocols when administered under appropriate medical supervision.
Lipitor: Advanced Lipid Management for Cardiovascular Risk Reduction
Lipitor (atorvastatin calcium) is a prescription medication classified as a statin, or HMG-CoA reductase inhibitor, designed to manage elevated cholesterol levels and reduce the risk of cardiovascular events. It functions by inhibiting the enzyme responsible for cholesterol production in the liver, thereby lowering low-density lipoprotein (LDL) cholesterol and triglycerides while increasing high-density lipoprotein (HDL) cholesterol. Clinically proven in extensive trials, Lipitor is indicated for primary and secondary prevention of cardiovascular disease, including myocardial infarction and stroke, in appropriate patient populations.
Lopressor: Precision Beta-Blocker Therapy for Cardiovascular Control
Lopressor (metoprolol tartrate) is a cardioselective beta-1 adrenergic receptor blocker indicated for the management of hypertension, angina pectoris, and hemodynamic stability following myocardial infarction. As a foundational agent in cardiovascular pharmacotherapy, it modulates sympathetic nervous system activity, reducing heart rate, myocardial contractility, and cardiac output. Its well-established efficacy and safety profile make it a first-line choice among clinicians for long-term cardiovascular risk mitigation. This agent is particularly valued for its predictable pharmacokinetics and selective action, minimizing extracardiac effects when dosed appropriately.